iDEL Therapeutics
GermanyEntry
2025
Hold
1yr
Status
Active
Who owns iDEL Therapeutics?
iDEL Therapeutics is currently owned by Gruenderfonds Ruhr through Gruenderfonds Ruhr II (2024 vintage), since 2025. Across its history, iDEL Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-07-03
Most recent investor
Gruenderfonds RuhrGruenderfonds Ruhr II · 2024 · VC
2 ownership periods · full history below
Key facts
HQGermany
SectorBiotech
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2025 · present
NRW.BANKActive
2025 · present(1yr) · NRW.Venture · 2006 · VC
Gruenderfonds RuhrActive
2025 · present(1yr) · Gruenderfonds Ruhr II · 2024 · VC
More from Gruenderfonds Ruhr II
Other portfolio companies in the same fund.
More Gruenderfonds Ruhr portfolio companies
From the same investor, across funds.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
US
UK
FranceTrack iDEL Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy iDEL Therapeutics?
6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on iDEL Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue